Skip to main content
OpenTrials

Clinical trial condition

Vaccinia

Explore clinical trials studying Vaccinia. Study availability and eligibility vary by location and protocol.

48 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Vaccinia trial results

Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

NCT00000767

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • JHU AVEG Pittsburgh, Pennsylvania, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
View Trial Details
Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

NCT00000866

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

NCT01143181

Conditions
Adenoviridae Infections, DNA Virus Infections, Double-stranded DNA Virus, +11 more
Locations
  • Loma Linda University Hospital Loma Linda, California, United States
  • Children's Hospital of LA Los Angeles, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • CHOC Children's Orange, California, United States
View all 37 locations
View Trial Details
Completed

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

NCT01394939

Conditions
CRC, Colonic Diseases, Colonic Neoplasms, +17 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Billings Clinic Cancer Center Billings, Montana, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details

Related conditions